The share of Chinese scientific publications in the world's top 10% most-cited in Pulmonary and Respiratory Medicine is projected to increase steadily from 2024 onwards, rising from 7.92% in 2024 to 8.48% by 2028. This upward trend indicates a positive movement from previous years, with an anticipated gradual year-on-year percentage growth. While 2023 marks the last known actual value, indicating the start of a consistent upward forecast, the expected compound annual growth rate (CAGR) over these five years signals a strategic reinforcement in China's research quality and impact in this field.
Future trends to watch for may include increased international collaboration, advancements in research technology, and policy changes aimed at further elevating China's global scientific status. Monitoring these factors will be crucial for understanding China's evolving position in pulmonary medicine research.
